1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HHIPL1 CTRPv2 pan-cancer AAC -0.091 0.02
mRNA SFTA2 CTRPv2 pan-cancer AAC 0.091 0.02
mRNA MPC1 CTRPv2 pan-cancer AAC -0.093 0.02
mRNA NEU3 CTRPv2 pan-cancer AAC -0.11 0.02
mRNA IL1RN CTRPv2 pan-cancer AAC 0.097 0.02
mRNA ARHGAP11A CTRPv2 pan-cancer AAC -0.091 0.02
mRNA BOC CTRPv2 pan-cancer AAC -0.094 0.02
mRNA RNF145 CTRPv2 pan-cancer AAC 0.098 0.02
mRNA RP11-96O20.4 CTRPv2 pan-cancer AAC 0.093 0.02
mRNA SP4 CTRPv2 pan-cancer AAC -0.094 0.02
Download CSV